Trial Profile
A retrospective study investigating efficacy of bevacizumab in patients with advanced colorectal cancer by evaluating flare phenomenon
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Aug 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 23 Aug 2016 New trial record